MyAverix Finance
NS · Pharmaceuticals
GlaxoSmithKline Pharmaceuticals Ltd (GLAXO)
Pharmaceuticals & Biotechnology
GlaxoSmithKline Pharmaceuticals Ltd (GLAXO) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-11, reported market cap is $406.59B, P/E ratio is 40.18, net margin is 22.0%, dividend yield is 2.37%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for GLAXO
GlaxoSmithKline Pharmaceuticals Ltd (GLAXO) — FAQ
What is GlaxoSmithKline Pharmaceuticals Ltd's market cap?
GlaxoSmithKline Pharmaceuticals Ltd (GLAXO) has a reported market cap of $406.59B (data as of 2026-07-11).
What is GLAXO's P/E ratio?
The price-to-earnings (P/E) ratio for GlaxoSmithKline Pharmaceuticals Ltd (GLAXO) is 40.18 (data as of 2026-07-11).
Does GlaxoSmithKline Pharmaceuticals Ltd pay a dividend?
GlaxoSmithKline Pharmaceuticals Ltd (GLAXO) shows a reported dividend yield of 2.37%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-11).
What sector is GlaxoSmithKline Pharmaceuticals Ltd in?
GlaxoSmithKline Pharmaceuticals Ltd (GLAXO) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
What exchange is GLAXO listed on?
GLAXO is listed on NS.
What is GlaxoSmithKline Pharmaceuticals Ltd's net margin?
GlaxoSmithKline Pharmaceuticals Ltd (GLAXO) reports a net margin of 22.0% (data as of 2026-07-11).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.